Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Strong Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Buy

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

XOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stock (XOMAP)

Pharmaceutical Preparations

https://www.xoma.com

XOMA Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes.

2200 POWELL STREET, SUITE 310
EMERYVILLE, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/16/2020

Market Cap

325,618,256

Shares Outstanding

980,000

Weighted SO

N/A

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

XOMAO --.--%

FBIOP --.--%

FRGAP --.--%

OTRKP --.--%

RILYP --.--%

Beta

0.9260

Last Div

2.1600

Range

21.4-26.479

Chg

0.0300

Avg Vol

1727

Mkt Cap

325618256

Exch

NASDAQ

Country

US

Phone

510 204 7200

DCF Diff

31.8978

DCF

-3.7778

Div Yield

0.0167

P/S

21.5902

EV Multiple

-15.8469

P/FV

3.2731

Div Yield %

1.6719

P/E

-17.9551

PEG

0.1307

Payout

-0.3002

Current Ratio

8.7136

Quick Ratio

8.7136

Cash Ratio

7.7305

DSO

354.0780

DIO

0.0000

Op Cycle

354.0780

DPO

789.4934

CCC

-435.4154

Gross Margin

0.9702

Op Margin

-1.2830

Pretax Margin

-1.1961

Net Margin

-1.1961

Eff Tax Rate

0.4919

ROA

-0.0749

ROE

-0.1934

ROCE

-0.0870

NI/EBT

1.0000

EBT/EBIT

0.9323

EBIT/Rev

-1.2830

Debt Ratio

0.4982

D/E

1.2122

LT Debt/Cap

0.5351

Total Debt/Cap

0.5480

Int Coverage

-27.2298

CF/Debt

-0.0735

Equity Multi

2.4330

Rec Turnover

1.0308

Pay Turnover

0.4623

Inv Turnover

0.0000

FA Turnover

39.4793

Asset Turnover

0.0626

OCF/Share

-0.7650

FCF/Share

-2.0262

Cash/Share

12.4195

OCF/Sales

-0.5845

FCF/OCF

2.6486

CF Coverage

-0.0735

ST Coverage

-1.4514

CapEx Coverage

-0.6066

Div&CapEx Cov

-0.4419

P/BV

3.2731

P/B

3.2731

P/S

21.5902

P/E

-17.9551

P/FCF

-13.9466

P/OCF

-36.7447

P/CF

-36.7447

PEG

0.1307

P/S

21.5902

EV Multiple

-15.8469

P/FV

3.2731

DPS

0.4700

Latest Headlines (EST)

GlobeNewswire Inc. Jan 02, 07:30 XOMA Announces Stock Repurchase Program of up to $50 Million GlobeNewswire Inc. Dec 20, 07:30 XOMA Declares Quarterly Preferred Stock Dividends GlobeNewswire Inc. Nov 07, 07:30 XOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder Value GlobeNewswire Inc. Oct 31, 07:30 XOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One’s Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)

Revenue Product Segmentation

Dividend History

Cash Value Ex-Dividend Date Declaration Date Record Date Pay Date
0.54 07/03/2024 05/15/2024 07/03/2024 07/15/2024
0.54 04/02/2024 02/21/2024 04/03/2024 04/15/2024
0.54 01/02/2024 10/18/2023 01/03/2024 01/16/2024
0.54 10/04/2023 07/26/2023 10/05/2023 10/16/2023
0.54 06/30/2023 05/17/2023 07/03/2023 07/17/2023
0.54 04/03/2023 02/22/2023 04/04/2023 04/17/2023
0.54 01/03/2023 10/26/2022 01/04/2023 01/17/2023
0.54 09/30/2022 09/22/2022 10/03/2022 10/17/2022
0.54 06/30/2022 05/18/2022 07/01/2022 07/15/2022
0.54 03/31/2022 03/17/2022 04/01/2022 04/15/2022
0.54 01/03/2022 12/01/2021 01/04/2022 01/18/2022
0.54 09/30/2021 07/28/2021 10/01/2021 10/15/2021
0.54 07/01/2021 05/21/2021 07/02/2021 07/15/2021
0.72 03/31/2021 03/17/2021 04/02/2021 04/15/2021